Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (Q167209)

From geokb
Revision as of 12:16, 8 September 2024 by Sky (talk | contribs) (‎Changed an Item: moved OpenAlex ID to its dedicated external ID datatype for consistency)
Study of CLL's genetic mutations and treatment options.
  • Chronic Lymphocytic Leukemia
  • Genomic Aberrations
  • BTK Inhibitors
  • Rituximab
  • Ibrutinib
  • Prognostic Factors
  • TP53 Mutation
  • Waldenström Macroglobulinemia
  • Immunoglobulin Mutation
  • Therapeutic Targets
Language Label Description Also known as
English
Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia
Study of CLL's genetic mutations and treatment options.
  • Chronic Lymphocytic Leukemia
  • Genomic Aberrations
  • BTK Inhibitors
  • Rituximab
  • Ibrutinib
  • Prognostic Factors
  • TP53 Mutation
  • Waldenström Macroglobulinemia
  • Immunoglobulin Mutation
  • Therapeutic Targets

Statements

0 references
0 references